A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study is a double-blind randomized, placebo-controlled, parallel-group, 12 week study performed in 2 centres in Sweden to assess the effect of Omega-3 carboxylic acids and fenofibrate on liver fat measured with magnetic resonance imaging (MRI) in patients with over-weight and hypertriglyceridemia.
Epistemonikos ID: 7c5ec05a29fa39e0086fa215d27a18125314a3fa
First added on: May 12, 2024